Joseph Mace is an Oncology physician. OpenAlex indexes 37 publications with 2,759 citations (h-index 14).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
725 6th Ave S Ste 2200
St Petersburg, FL 337014553
Telephone
727-821-0017Provider last certified this registry record 8 Jan 2026.
Industry payments
68 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Daiichi Sankyo Inc.Program year202510 payments
- Novartis Pharmaceuticals CorporationProgram year20259 payments
- Gilead Sciences, Inc.Program year20259 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Blood & clotting
76.4%Parenteral Iron Replacement68.6%Iron sucrose100%Part B, office-administered≥41 patientsErythropoiesis-stimulating Agent7.5%Epoetin alfa100%Part B, office-administered≥20 patients+ 2 more classes in this area
Musculoskeletal
10.8%RANK Ligand Inhibitor10.5%Denosumab100%Part B, office-administered≥26 patientsBisphosphonate0.2%Zoledronic acid100%Part B, office-administered≥13 patients+ 1 more class in this area
Anti-infectives
5.4%Human Immunoglobulin G5.2%Immune globulin100%Part B, office-administered≥11 patientsPenicillins with extended spectrum0.1%Amoxicillin-Clavulanate Potass100%Part D≥27 patients+ 2 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2004–2005 per NIH RePORTER. The latest:
- THE INFLUENCE OF TOURNIQUET TIME ON CEREBRAL EMBOLIC EVENTS IN ELDERLY PATIENTS
University of Florida
FY2005$23,971M01RR000082 - The Influence of Tourniquet Time on Cerebral Embolic Events in Elderly Patients
University of Florida
FY2004$66,722M01RR000082
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Carl June, MD
University of Pennsylvania
Rainer Storb
University of Washington
Christina Fitzmaurice, MD
Larry Norton, MD
Memorial Sloan Kettering Cancer Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”